After finishing at $1.58 in the prior trading day, Clearside Biomedical Inc (NASDAQ: CLSD) closed at $1.40, down -11.39%. In other words, the price has decreased by -$0.1800 from its previous closing price. On the day, 714436 shares were traded.
Ratios:
Our goal is to gain a better understanding of CLSD by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.42 and its Current Ratio is at 4.42.
On July 29, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $10.
On May 13, 2020, ROTH Capital started tracking the stock assigning a Buy rating and target price of $8.ROTH Capital initiated its Buy rating on May 13, 2020, with a $8 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 20 ’24 when Chong Ngai Hang Victor bought 30,000 shares for $1.60 per share. The transaction valued at 48,000 led to the insider holds 30,000 shares of the business.
WHITMORE BRADFORD T bought 444,444 shares of CLSD for $599,999 on Feb 07 ’24. The 10% Owner now owns 4,495,034 shares after completing the transaction at $1.35 per share. On Jan 19 ’24, another insider, LASEZKAY GEORGE M, who serves as the CEO of the company, sold 18,000 shares for $1.27 each. As a result, the insider received 22,860 and left with 466,577 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLSD now has a Market Capitalization of 103.86M and an Enterprise Value of 75.96M. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.71. Its current Enterprise Value per Revenue stands at 9.23 whereas that against EBITDA is -3.29.
Stock Price History:
Over the past 52 weeks, CLSD has reached a high of $2.12, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is 1.4579, while the 200-Day Moving Average is calculated to be 1.1355.
Shares Statistics:
The stock has traded on average 351.48K shares per day over the past 3-months and 410.95k shares per day over the last 10 days, according to various share statistics. A total of 74.72M shares are outstanding, with a floating share count of 63.00M. Insiders hold about 15.69% of the company’s shares, while institutions hold 13.32% stake in the company. Shares short for CLSD as of Mar 15, 2024 were 339.93k with a Short Ratio of 0.97, compared to 161.93k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.45% and a Short% of Float of 0.48%.
Earnings Estimates
Its stock is currently analyzed by 5 different market analysts. On average, analysts expect EPS of -$0.14 for the current quarter, with a high estimate of -$0.12 and a low estimate of -$0.16, while EPS last year was -$0.15. The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.12 and low estimates of -$0.16.
Analysts are recommending an EPS of between -$0.46 and -$0.63 for the fiscal current year, implying an average EPS of -$0.53. EPS for the following year is -$0.56, with 5 analysts recommending between -$0.44 and -$0.66.
